Adaptive Biotechnologies (ADPT) Gross Profit Growth (3y) (2021 - 2026)
Adaptive Biotechnologies (ADPT) Gross Profit Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 4.04% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 2.86% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 60.04% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 2.33% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 3.75% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 10.79% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 1.70% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 3.67% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 9.71% |
| 10 | Adaptive Biotechnologies | 4.23 Bn | 3.89 Bn | 51.39 Mn | 91.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 91.59% |
| Mar 31, 2026 | 40.11% |
| Dec 31, 2025 | 11.46% |
| Sep 30, 2025 | 32.05% |
| Jun 30, 2025 | 10.33% |
| Mar 31, 2025 | 11.73% |
| Dec 31, 2024 | 7.66% |
| Sep 30, 2024 | 5.60% |
| Jun 30, 2024 | -4.88% |
| Mar 31, 2024 | -5.75% |
| Dec 31, 2023 | 2.98% |
| Sep 30, 2023 | -2.83% |
| Jun 30, 2023 | -38.12% |
| Mar 31, 2023 | 6.80% |
| Dec 31, 2022 | 28.35% |
| Sep 30, 2022 | 17.19% |
| Jun 30, 2022 | 22.88% |
| Mar 31, 2022 | 49.06% |
| Dec 31, 2021 | 25.53% |
| Sep 30, 2021 | 28.81% |